(CBT) Cabot - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270551013
CBT EPS (Earnings per Share)
CBT Revenue
CBT: Carbon, Additives, Conductive, Silica, Aerogel
Cabot Corporation is a leading global specialty chemicals and performance materials company, operating through two main segments: Reinforcement Materials and Performance Chemicals. The companys products play a crucial role in various industries, including automotive, industrial, electronics, and consumer goods. Its reinforcing carbons and engineered elastomer composites solutions are used in tire manufacturing and industrial products, while its specialty carbons and conductive additives are used in inks, coatings, plastics, and batteries. Additionally, Cabots fumed silica and alumina are used in a range of applications, from adhesives and cosmetics to batteries and pharmaceuticals.
The companys diverse product portfolio also includes aerogel, a high-performance insulation material, and masterbatch and conductive compound products used in various industries. Cabots products are sold through a global network of distributors and sales representatives, with a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. With a rich history dating back to 1882, Cabot Corporation is headquartered in Boston, Massachusetts, and is committed to delivering innovative solutions to its customers.
From a technical analysis perspective, Cabots stock price has been trending downwards, with the current price of $75.06 below its 50-day SMA of $76.84 and 200-day SMA of $92.47. The ATR of 1.98 indicates a relatively low volatility, but the stock is currently trading near its 52-week low of $72.04. Considering the fundamental data, Cabots market capitalization stands at $4012.58M USD, with a P/E ratio of 9.69 and a forward P/E of 10.32, indicating a relatively undervalued stock. The companys RoE of 31.13% suggests a strong profitability.
Based on the technical and fundamental data, a forecast for Cabot Corporations stock price could be made. With the current price near its 52-week low and a relatively low P/E ratio, the stock may be due for a rebound. If the companys RoE continues to be strong, it could drive the stock price upwards. However, the downward trend in the stock price and the high 200-day SMA may indicate a longer-term bearish trend. A potential trading strategy could be to buy the stock at the current price, with a stop-loss at around $72.04, and a target price of $80-$85, based on the stocks historical volatility and fundamental data.
Additional Sources for CBT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CBT Stock Overview
Market Cap in USD | 4,014m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 1980-11-05 |
CBT Stock Ratings
Growth Rating | 50.0 |
Fundamental | 53.0 |
Dividend Rating | 60.2 |
Rel. Strength | -19.9 |
Analysts | 3.6 of 5 |
Fair Price Momentum | 71.46 USD |
Fair Price DCF | 105.38 USD |
CBT Dividends
Dividend Yield 12m | 2.11% |
Yield on Cost 5y | 5.35% |
Annual Growth 5y | 3.84% |
Payout Consistency | 89.5% |
Payout Ratio | 23.6% |
CBT Growth Ratios
Growth Correlation 3m | -72.4% |
Growth Correlation 12m | -75.4% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 18.06% |
CAGR/Max DD 5y | 0.48 |
Sharpe Ratio 12m | -1.78 |
Alpha | -31.18 |
Beta | 0.887 |
Volatility | 33.75% |
Current Volume | 260.4k |
Average Volume 20d | 330.5k |
As of June 24, 2025, the stock is trading at USD 74.57 with a total of 260,416 shares traded.
Over the past week, the price has changed by +0.15%, over one month by +1.39%, over three months by -10.77% and over the past year by -20.96%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Cabot (NYSE:CBT) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.03 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CBT is around 71.46 USD . This means that CBT is currently overvalued and has a potential downside of -4.17%.
Cabot has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CBT.
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, CBT Cabot will be worth about 78.8 in June 2026. The stock is currently trading at 74.57. This means that the stock has a potential upside of +5.69%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 83.6 | 12.1% |
Analysts Target Price | 83.6 | 12.1% |
ValueRay Target Price | 78.8 | 5.7% |